DexCom (NASDAQ: DXCM), which makes glucose monitoring systems, is still slogging through a correction that began in August. However, analysts remain optimistic about the stock’s prospects.
DexCom (NASDAQ: DXCM), which makes glucose monitoring systems, is still slogging through a correction that began in August. However, analysts remain optimistic about the stock’s prospects.